A prospective, Single Blind, Multi-center, Randomized Trial to Compare the TAXUS Element_ Coronary Stent System against the XIENCE Prime_ Coronary Stent System in the treatment of a Diabetic Patient PopulatiOn in India.

Trial Profile

A prospective, Single Blind, Multi-center, Randomized Trial to Compare the TAXUS Element_ Coronary Stent System against the XIENCE Prime_ Coronary Stent System in the treatment of a Diabetic Patient PopulatiOn in India.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Paclitaxel (Primary) ; Everolimus
  • Indications Coronary artery disease; Coronary artery restenosis; Ischaemia
  • Focus Therapeutic Use
  • Acronyms TUXEDO
  • Most Recent Events

    • 14 Oct 2015 Primary endpoint has not been met. (Target vessel failure rate), as per an article published in the New England Journal of Medicine
    • 14 Oct 2015 Status changed from recruiting to completed, as per an article published in the New England Journal of Medicine
    • 14 Oct 2015 Results published in the New England Journal of Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top